Director, TAIP TA Lead – Trial Analytics, Insights & Planning (TAIP) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Advanced degree preferred (MBA, MSc, MPH, PharmD, PhD, or equivalent) in a relevant field
8+ years in management (incomplete in description, but implied as managerial experience)

Responsibilities

Lead analytics strategy and delivery across a portfolio of trials within assigned therapeutic area (TA)
Guide, support, and review work across study-level analytics leads, acting as both coach and strategic sounding board
Track delivery progress across trials, escalating risks and ensuring alignment with trial milestones and enterprise priorities
Partner with clinical, medical, and operational leadership, shaping trial strategy and portfolio-level planning through data-driven insights
Ensure cross-trial consistency and innovation in forecasting, feasibility modelling, performance dashboards, and protocol analytics
Promote global collaboration, coordinating across teams to ensure effective, scalable delivery
Lead discussions on cost implications of country mix and study design decisions at the portfolio level
Promote study optimization analytics across trials, including evaluation of patient and site burden and competitive landscape data
Coordinate field-based insights into TA-wide feasibility and site prioritization approaches
Champion use of platforms, tools, and data infrastructure that support delivery excellence
Integrate analytics with clinical supply planning where relevant to ensure delivery-readiness
Influence the evolution of TAIP capabilities, helping define best practices and raise the bar on analytics excellence across trials
Apply critical thinking to analyze complex data, challenge assumptions, and generate strategic, evidence-based recommendations

Skills

Key technologies and capabilities for this role

Trial AnalyticsFeasibility ModelingStrategic PlanningResource PlanningData-Driven InsightsClinical DevelopmentAnalytics StrategyQuality ControlLeadershipCoaching

Questions & Answers

Common questions about this position

What is the employment type for this position?

The position is full time.

Is this role remote or does it require office presence?

This information is not specified in the job description.

What experience areas are preferred for this role?

Experience in one or more of the following areas is preferred: Oncology, Neuroscience, Cell Therapy, Hematology, Immunology, or Cardiovascular.

What is the company culture like at Bristol Myers Squibb?

The culture is challenging, meaningful, and life-changing, with uniquely interesting work, opportunities to grow alongside high-achieving teams, and a focus on balance and flexibility.

What makes a strong candidate for the TAIP TA Lead role?

A strong candidate has a foundation in clinical trial science and applied analytics, leadership experience to own analytics strategy for a therapeutic area portfolio, and expertise in areas like Oncology, Neuroscience, Cell Therapy, Hematology, Immunology, or Cardiovascular.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free